Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 746970, 17 pages
http://dx.doi.org/10.1155/2015/746970
Research Article

Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling

1Institute of Biomedical Engineering, Capital Medical University, Beijing 100069, China
2Institute of Basic Medical Science, Peking Union Medical College, Qinghua University, No. 5 Dong Dan San Tiao, Beijing 100005, China

Received 16 July 2014; Revised 15 September 2014; Accepted 22 September 2014

Academic Editor: Jiangning Song

Copyright © 2015 Dongguo Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. O. Nielsen, J. S. Parker, S. Leung et al., “A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer,” Clinical Cancer Research, vol. 16, no. 21, pp. 5222–5232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Uchida, T. Suda, and K. Ishiguro, “Effect of chemotherapy for luminal a breast cancer,” Yonago Acta Medica, vol. 56, no. 2, pp. 51–56, 2013. View at Google Scholar · View at Scopus
  3. A. Prat, B. Adamo, M. C. U. Cheang, C. K. Anders, L. A. Carey, and C. M. Perou, “Molecular characterization of basal-like and non-basal-like triple-negative breast cancer,” Oncologist, vol. 18, no. 2, pp. 123–133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Pinkel and D. G. Albertson, “Array comparative genomic hybridization and its applications in cancer,” Nature Genetics, vol. 37, no. 6, pp. S11–S17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Bergamaschi, Y. H. Kim, P. Wang et al., “Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer,” Genes Chromosomes and Cancer, vol. 45, no. 11, pp. 1033–1040, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. H. G. Russnes, H. K. Vollan, O. C. Lingjaerde et al., “Genomic architecture characterizes tumor progression paths and fate in breast cancer patients,” Science Translational Medicine, vol. 2, no. 38, p. 38ra47, 2010. View at Publisher · View at Google Scholar
  7. J. R. Pollack, T. Sørlie, C. M. Perou et al., “Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 20, pp. 12963–12968, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H. K. Solvang, O. C. Lingjærde, A. Frigessi, A.-L. Børresen-Dale, and V. N. Kristensen, “Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer,” BMC Bioinformatics, vol. 12, article 197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. U. D. Akavia, O. Litvin, J. Kim et al., “An integrated approach to uncover drivers of cancer,” Cell, vol. 143, no. 6, pp. 1005–1017, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Liu, X.-S. Zhang, and S. Zhang, “Breast tumor subgroups reveal diverse clinical prognostic power,” Scientific Reports, vol. 4, Article ID 04002, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Román-Pérez, P. Casbas-Hernández, J. R. Pirone et al., “Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients,” Breast Cancer Research, vol. 14, no. 2, article R51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Zhang, Q. Li, J. Liu, and X. J. Zhou, “A novel computational framework for simultaneous integration of multiple types of genomic data to identify microrna-gene regulatory modules,” Bioinformatics, vol. 27, no. 13, pp. i401–i409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Zhang, C. C. Liu, W. Li, H. Shen, P. W. Laird, and X. J. Zhou, “Discovery of multi-dimensional modules by integrative analysis of cancer genomic data,” Nucleic Acids Research, vol. 40, no. 19, pp. 9379–9391, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Enerly, I. Steinfeld, K. Kleivi et al., “miRNA-mRNA integrated analysis reveals roles for mirnas in primary breast tumors,” PLoS ONE, vol. 6, no. 2, Article ID e16915, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Hua, P. Zhou, L. Li, H. Liu, and Z. Yang, “Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling,” Journal of Theoretical Biology, vol. 331, pp. 1–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Hua, L. Li, and P. Zhou, “Identifying breast cancer subtype related mirnas from two constructed mirnas interaction networks in silico method,” BioMed Research International, vol. 2013, Article ID 798912, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. V. J. Weigman, H.-H. Chao, A. A. Shabalin et al., “Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival,” Breast Cancer Research and Treatment, vol. 133, no. 3, pp. 865–880, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. V. G. Tusher, R. Tibshirani, and G. Chu, “Significance analysis of microarrays applied to the ionizing radiation response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5116–5121, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Chandra, R. Girijadevi, A. S. Nair, S. S. Pillai, and R. M. Pillai, “MTar: a computational microRNA target prediction architecture for human transcriptome,” BMC Bioinformatics, vol. 11, no. 1, article S2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Pique-Regi, J. Monso-Varona, A. Ortega, R. C. Seeger, T. J. Triche, and S. Asgharzadeh, “Sparse representation and Bayesian detection of genome copy number alterations from microarray data,” Bioinformatics, vol. 24, no. 3, pp. 309–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Shen, S. Li, L. Zhang et al., “An integrated approach to uncover driver genes in breast cancer methylation genomes,” PLoS ONE, vol. 8, no. 4, Article ID e61214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. T. D. Le, L. Liu, B. Liu et al., “Inferring microRNA and transcription factor regulatory networks in heterogeneous data,” BMC Bioinformatics, vol. 14, article 92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Audenaert, T. V. Parys, F. Brondel et al., “CyClus3D: a cytoscape plugin for clustering network motifs in integrated networks,” Bioinformatics, vol. 27, no. 11, article 1587, 2011. View at Google Scholar
  24. Y. Benjamini, “Discovering the false discovery rate,” Journal of the Royal Statistical Society. Series B. Statistical Methodology, vol. 72, no. 4, pp. 405–416, 2010. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  25. Z. Gu and J. Wang, “CePa: an R package for finding significant pathways weighted by multiple network centralities,” Bioinformatics, vol. 29, no. 5, pp. 658–660, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. B. N. Davis, A. C. Hilyard, G. Lagna, and A. Hata, “SMAD proteins control DROSHA-mediated microRNA maturation,” Nature, vol. 454, no. 7200, pp. 56–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. H. I. Suzuki, K. Yamagata, K. Sugimoto, T. Iwamoto, S. Kato, and K. Miyazono, “Modulation of microRNA processing by p53,” Nature, vol. 460, no. 7254, pp. 529–533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Blenkiron, L. D. Goldstein, N. P. Thorne et al., “MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype,” Genome Biology, vol. 8, no. 10, article R214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. C. D. May, N. Sphyris, K. W. Evans, S. J. Werden, W. Guo, and S. A. Mani, “Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression,” Breast Cancer Research, vol. 13, no. 1, article 202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. V. J. Findlay, “Micrornas and breast cancer,” The Open Cancer Journal, vol. 3, no. 1, pp. 55–61, 2010. View at Google Scholar · View at Scopus
  31. G. Molyneux, F. C. Geyer, F.-A. Magnay et al., “BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells,” Cell Stem Cell, vol. 7, no. 3, pp. 403–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Yang, R. Chaerkady, M. A. Beer, J. T. Mendell, and A. Pandey, “Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach,” Proteomics, vol. 9, no. 5, pp. 1374–1384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Wang, K. A. Eckert, A. R. Zomorrodi et al., “Down-regulation of HtrA1 activates the Epithelial-Mesenchymal transition and ATM DNA damage response pathways,” PLoS ONE, vol. 7, no. 6, Article ID e39446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Kawai and A. Amano, “BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex,” The Journal of Cell Biology, vol. 197, no. 2, pp. 201–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Nishida, K. Mimori, M. Fabbri et al., “MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab,” Clinical Cancer Research, vol. 17, no. 9, pp. 2725–2733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Li, R. Duan, F. Kooy, S. L. Sherman, W. Zhou, and P. Jin, “Germline mutation of microRNA-125a is associated with breast cancer,” Journal of Medical Genetics, vol. 46, no. 5, pp. 358–360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. H. M. Heneghan, N. Miller, A. J. Lowery, K. J. Sweeney, and M. J. Kerin, “MicroRNAs as novel biomarkers for breast cancer,” Journal of Oncology, vol. 2010, Article ID 950201, 7 pages, 2010. View at Publisher · View at Google Scholar
  38. F. J. Couch, M. R. Johnson, K. G. Rabe et al., “The prevalence of BRCA2 mutations in familial pancreatic cancer,” Cancer Epidemiology, Biomarkers & Prevention, vol. 16, no. 2, pp. 342–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Wang, Y.-Q. Xiao, Z.-Q. Liu et al., “Network-guided genetic screening for metastasis-related microRNA-200c in breast cancer,” Tumor, vol. 33, no. 2, pp. 111–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Kim, M. Kon, and C. DeLisi, “Pathway-based classification of cancer subtypes,” Biology Direct, vol. 7, article 21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. J. J. Goeman, S. van de Geer, F. de Kort, and H. C. van Houwellingen, “A global test for groups fo genes: testing association with a clinical outcome,” Bioinformatics, vol. 20, no. 1, pp. 93–99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. X. R. Yang, M. E. Sherman, D. L. Rimm et al., “Differences in risk factors for breast cancer molecular subtypes in a population-based study,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 439–443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Zvelebil, E. Oliemuller, Q. Gao et al., “Embryonic mammary signature subsets are activated in Brca1−/− and basal-like breast cancers,” Breast Cancer Research, vol. 15, no. 2, article R25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Shubbar, A. Kovács, S. Hajizadeh et al., “Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome,” BMC Cancer, vol. 13, article 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Dutta, L. Pusztai, Y. Qi et al., “A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes,” British Journal of Cancer, vol. 106, no. 6, pp. 1107–1116, 2012. View at Publisher · View at Google Scholar · View at Scopus